The main focus of our research is the use of Cancer Nanotechnology for Precision Medicine in order to tackle crucial medical problems involved in the development of novel and highly effective diagnostic and therapy platforms for cancer.
Determining the response profile of a tumor, detecting key driver players in tumor progression, and trying to disable those drivers with targeted therapies and engineered materials so as to “smash” the brakes on malignant and metastatic cells to control proliferation is the modus operandus of our research.
Cancer Nanotechnology is becoming a burgeoning field and we are sure that will aim to bring up reality to the Precision Medicine initiative. It is now crucial to empower the potential of Nanomedicine to differentially combat cancer using smart and targeted platforms that mediate highly selective therapies within the tumor microenvironment.
The lack of standardized means to treat and profile the tumor microenvironment calls for a paradigm shift in the way we view and treat cancer. Is in this paradigm that our research focus: tackling real biomedical problems and develop smart materials to beat cancer.
Check groups website at www.conde-nanolab.com
European Research Council - ERC Starting Grant: ERC-StG-2019-848325 – GelGeneCircuit: Profiling therapy and heterogeneity in cancer using bioresponsive nanohydrogels for the delivery of logic multicolor genetic circuits (2019-2024). Funding 1.5M€
FCT Grant PTDC/BTM-MAT/4738/2020 – Biomimetic cell membrane-coated vitamin E-based micelles for multimodal pancreatic cancer nanotheranostics (2020-2023). Funding 250K€
João Conde, principal investigator of the Cancer Nanomedicine at NOVA Medical School, published a study in the journal Advanced Healthcare Materials, which evaluates the potential of a new therapeutic system of nanoparticles for the treatment of breast cancer.
NOVA Medical School will be present at Ciência 2022, the largest meeting of Science and Technology in Portugal, with full representation of its research with its four Research Units and three Associate Laboratories, during for the entire duration of the event at Centro de Congressos de Lisboa.
Five researchers from NOVA Medical School are part of the ranking of Elsevier, one of the most recognized publishers of scientific publications.
NOVA Medical SchoolCampo Mártires da Pátria, 1301169-056 LisboaPORTUGAL
GeneralTel.: +351 218 803 000
News and Events
Awards and Honours